Medline Industries, LP is recalling 15 units of Medline Perfusion Syringes (REF: DYNJ39223C) containing specific BD Luer Tip Caps. The recall was initiated because the tip caps failed routine biocompatibility testing conducted by the supplier, Becton Dickinson (BD). While the cap covers a small area and does not touch patients directly, materials from the cap could potentially interact with the liquid inside the syringe before use.
Failure of biocompatibility testing means the materials in the tip cap could potentially cause adverse health effects such as skin sensitization, irritation, fever-inducing reactions, or systemic toxicity. The severity of the risk depends on the nature and duration of the contact between the syringe contents and the defective cap.
15 units affected.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.